Aerie Pharmaceuticals, Duke spinoff, tests glaucoma treatment and sees stock boost - Triangle Business Journal
AERIE PHARMACEUTICALS INC - FORM 8-K - EX-99.1 - April 9, 2014
Aerie Pharmaceuticals to Establish Athlone Manufacturing Plant | Industry & Business
Aerie Pharmaceuticals – Capital Sign Solutions
Aerie Pharmaceuticals Reports Positive 12-Month Safety Results for Rhopressa – Eyewire News
Aerie Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update - ADVFN
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Aerie Pharmaceuticals
Aerie Pharmaceuticals to Present at Two Investor Conferences in March | Business Wire
Aerie Pharmaceuticals, Inc. (AERI) Latest Press Releases & Corporate News - Yahoo Finance
News - Aerie Pharmaceuticals
This May Be A Good Time To Pick Up Aerie Pharmaceuticals In 2018 (NASDAQ:AERI) | Seeking Alpha
Aerie Pharmaceuticals Inc shares jump on FDA approval of glaucoma drug Rocklatan
Our Eye Care Products | Aerie Pharmaceuticals, Inc.
The Verdict On Aerie Pharmaceuticals (NASDAQ:AERI) | Seeking Alpha
Durham-based Aerie Pharma sees positive study results for eye pressure drug | WRAL TechWire
Aerie Pharmaceuticals to Acquire Avizorex Pharma to Expand its Footprint in Ophthalmology | PharmaShots
Company Aerie Pharmaceuticals Inc. News, Employees and Funding Information, Bedminster, NJ
Why Aerie Pharmaceuticals Inc (NASDAQ: AERI) stock is going gangbusters today
Sign Up For VISIONaerieS™
Public Device & Biopharma Ophthalmology Company Showcase - Aerie Phar…
Aerie Pharmaceuticals (AERI) Stock | Helping Treatment with Glaucoma - Warrior Trading News
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Advertiser.ie - Aerie Pharmaceuticals establishes state of the art manufacturing facility in Athlone
